SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...
SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...
SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat ...
Laertis Ikonomou, PhD, associate professor of oral biology, is the principal investigator of a two-year, $435,167 R21 grant ...
SciSparc Ltd. (NASDAQ: SPRC) stock is surging on Thursday, with a session volume of 58.21 million compared to the average volume of 2.49 million as per data from Benzinga Pro.
Investing.com -- SciSparc Ltd. (NASDAQ:SPRC) stock surged 45.5% in premarket trading Thursday after the clinical-stage pharmaceutical company announced plans to launch a quantum computing initiative ...
InvestorsHub on MSN
SciSparc Shares Surge Following Launch of Quantum Computing Program
SciSparc Ltd. (NASDAQ:SPRC) jumped 45.5% in premarket trading Thursday after announcing a new quantum computing initiative focused on 3D protein modeling. The clinical-stage pharmaceutical company, ...
The latest announcement is out from SciSparc Ltd. ( (SPRC) ).
EP2 receptors are a druggable target; blocking them can relieve pain without affecting the healing inflammation, offering a ...
AZoRobotics on MSN
MIT Introduces First Articulated 3D Model of the Fetus, Advancing MRI-Based Prenatal Assessment
This innovative 3D model from MIT decouples fetal shape and motion, enhancing MRI analysis and offering critical insights for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback